Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract.

Trial Profile

Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Oct 2015

At a glance

  • Drugs Vinflunine (Primary)
  • Indications Urogenital cancer
  • Focus Therapeutic Use
  • Acronyms JASiMA
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 13 Oct 2015 Status changed from recruiting to completed as reported by European Clinical Trials database.
    • 02 Jun 2012 Actual initiation date (29 Aug 2011) and additional trial location (Italy) added as reported by European Clinical Trials Database.
    • 13 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top